设为首页 电子邮箱 联系我们

本刊最新招聘信息请见“通知公告”!  本刊投稿系统试运行中,欢迎投稿!如投稿有问题,可直接将稿件发送至zgyy8888@163.com

 
网站首页杂志简介编委会成员本刊稿约编辑部照片过刊目录广告合作读者论坛联系我们
位置:首页 >> 电子期刊 >> 正文
射频导管消融术对室上性心动过速患者长期生活质量的影响
作者:王勇 晁鹏 任澎 
单位:830001 乌鲁木齐 新疆维吾尔自治区人民医院心内科 
关键词:心动过速 室上性 导管消融术 长期生活质量 
分类号:R 541.7
出版年,卷(期):页码:2017,12(11):1605-1608
摘要:

【摘要】目的    探讨射频导管消融术对室上性心动过速(SVT)患者长期生活质量的影响。方法    选取2008年1月至2010年12月于新疆维吾尔自治区人民医院行十二导联心电图或24 h动态心电图确诊为SVT患者584例。将患者分为手术组(260例)与非手术组(324例),手术组患者行射频导管消融术治疗,非手术组给予药物治疗。随访患者5年,记录并比较2组患者治疗后2、5年疾病复发率、满意度、全因死亡率、心血管事件发生率和SF-36健康状况调查问卷评价情况。结果    治疗后2年,584例患者中失访68例,其中手术组33例,非手术组35例;成功随访516例,其中手术组227例,非手术组289例。治疗后5年(排除治疗后2年的结果),失访42例,其中手术组20例,非手术组22例;成功随访474例,其中手术组207例,非手术组267例。手术组治疗后2、5年疾病复发率低于非手术组[29.1%(66/227)比40.5%(117/289)、35.7%(74/207)比47.6%(127/267)],差异有统计学意义(P<0.05)。手术组治疗后2、5年满意度高于非手术组[67.4%(153/227)比59.5%(172/289)、76.3%(158/207)比50.9%(136/267)],差异有统计学意义(P<0.05)。手术组治疗后2、5年全因死亡率与心血管事件发生率均明显低于非手术组[全因死亡率:4.8%(11/227)比8.7%(25/289)、6.3%(13/207)比11.2%(30/267);心血管事件:1.8%(4/227)比5.5%(16/289)、2.4%(5/207)比8.6%(23/267)],差异均有统计学意义(均P<0.05);2组治疗后5年全因死亡率和心血管事件发生率分别与本组治疗后2年比较,差异均无统计学意义(均P>0.05)。治疗前,2组患者SF-36总分比较,差异无统计学意义(P>0.05)。治疗后2、5年,手术组SF-36总分均明显高于非手术组[(578±113)分比(539±106)分、(597±128)分比(503±119)分],差异均有统计学意义(均P<0.05)。结论    射频导管消融术治疗SVT患者在复发率、满意度、全因死亡率、心血管事件发生率及生活质量方面均优于药物治疗。

Effect of radiofrequency catheter ablation on long-term quality of life in patients with supraventricular tachycardia
Wang Yong, Chao Peng, Ren Peng
Department of Cardiology, People′s Hospital of Xinjiang Uygur Autonomous Region, Urumqi 830001, China
Corresponding author: Ren Peng, Email: renpengcvd@126.com
【Abstract】Objective    To investigate the effect of radiofrequency catheter ablation on long-term quality of life in patients with supraventricular tachycardia(SVT). Methods    Totally 584 patients undergoing SVT were enrolled from January 2008 to December 2010 in People′s Hospital of Xinjiang Uygur Autonomous Region; 260 patients had radiofrequency catheter ablation(operation group) and 324 patients had drug therapy(non-operation group). All patients were followed up for 5 years; recurrence rate, patient degree of satisfaction, all-cause mortality rate, cardiovascular event rate and score of SF-36 health scale were analyzed. Results    Among 584 patients, 68 cases(33 cases in operation group and 35 cases in non-operation group) were lost of follow-up in 2 years, 227 cases in operation group and 289 cases in non-operation group were successfully followed; 42 patients(20 cases in operation group and 22 cases in non-operation group) were lost of follow-up during 3-5 years; 207 cases in operation group and 267 cases in non-operation group had complete 5-year follow-up data. The 2, 5-year recurrence rates in operation group were significantly lower than those in non-operation group[29.1%(66/227) vs 40.5%(117/289), 35.7%(74/207) vs 47.6%(127/267)](P<0.05). The 2, 5-year satisfaction rates in operation group were significantly higher than those in non-operation group[67.4%(153/227) vs 59.5%(172/289), 76.3%(158/207) vs 50.9%(136/267)](P<0.05). The 2, 5-year all-cause mortality rates and cardiovascular event rates in operation group were significantly lower than those in non-operation group[all-cause mortality: 4.8%(11/227) vs 8.7%(25/289), 6.3%(13/207) vs 11.2%(30/267); cardiovascular events: 1.8%(4/227) vs 5.5%(16/289), 2.4%(5/207) vs 8.6%(23/267)](P<0.05). There were no significant differences between the 2-year and 5-year all-cause mortality rate and cardiovascular event rate in both groups(P>0.05). The 2, 5-year SF-36 scores in operation group were significantly higher than those in non-operation group[(578±113)scores vs (539±106)scores, (597±128)scores vs (503±119)scores](P<0.05). Conclusion    Radiofrequency catheter ablation is superior to drug therapy in relapse rate, patient satisfaction, all-cause mortality, cardiovascular events and quality of life in patients with SVT.
【Key words】Tachycardia, supraventricular;Catheter ablation;Long-term quality of life

基金项目:
作者简介:
参考文献:

[1]Rodriguez BC, Leal S, Calvimontes G, et al. Cost-effectiveness of radiofrequency ablation for supraventricular tachycardia in guatemala: patient outcomes and economic analysis from a low-middle-income country[J]. Value Health Reg Issues, 2015(8):92-98. DOI: 10.1016/j.vhri.2015.06.002.
[2]Díaz-Infante E, Macías Gallego A, Ferrero de Loma-Osorio . Spanish catheter ablation registry. 11th official report of the spanish society of cardiology working group on electrophysiology and arrhythmias(2011)[J]. Rev Esp Cardiol(Engl Ed), 2012,65(10):928-936. DOI: 10.1016/j.recesp.2012.06.008.
[3]Cappato R, Calkins H, Chen S A, et al. Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation[J]. Circulation, 2005,111(9):1100-1105. DOI: 10.1161/01.CIR.0000157153.30978.67.
[4]赵战勇,李志忠,张京梅,等.射频消融术治疗阵发性室上性心动过速临床分析[J].中国医药,2013,8(6):764-766. DOI: 10.3760/cma.j.issn.1673-4777.2013.06.016.
Zhao ZY, Li ZZ, Zhang JM, et al. Clinical analysis of supraventricular tachycardia treated by catheter radiofrequency ablation[J]. China Medicine, 2013,8(6):764-766. DOI: 10.3760/cma.j.issn.1673-4777.2013.06.016.
[5]刘定坤,韦开福.应用三维电解剖标测系统零X线透视下射频消融治疗阵发性室上性心动过速[J].中国循证心血管医学杂志,2015,7(5):652-655. DOI: 10.3969/j.issn.1674-4055.2015.05.21.
Liu DK, Wei KF. Non-X-ray fluoroscopic radiofrequency catheter ablation for treating paroxysmal supraventricular tachycardia guided by 3D electroanatomical mapping system[J]. Chinese Journal of Evidence-Bases Cardiovascular Medicine, 2015,7(5):652-655. DOI: 10.3969/j.issn.1674-4055.2015.05.21.
[6]赵渊,陈宗宁,杨松生,等.射频消融手术对阵发性室上性心动过速患者生活质量影响的分析[J].中国心血管病研究,2015,13(12):1131-1134. DOI: 10.3969/j.issn.1672-5301.2015.12.019.
Zhao Y, Chen ZN, Yang SS, et al. The impacts RFCA on the quality of life in PSVT patients[J]. Chinese Journal of Cardiovascular Research, 2015,13(12):1131-1134. DOI: 10.3969/j.issn.1672-5301.2015.12.019.
[7]Brachmann J, Lewalter T, Kuck KH, et al. Long-term symptom improvement and patient satisfaction following catheter ablation of supraventricular tachycardia: insights from the German ablation registry[J]. Eur Heart J, 2017,38(17):1317-1326. DOI: 10.1093/eurheartj/ehx101.
[8]Lewalter T, Lickfett L, Weiss C, et al. Largest amplitude ablation" is the optimal approach for typical atrial flutter ablation: a subanalysis from the AURUM 8 study[J]. J Cardiovasc Electrophysiol, 2012,23(5):479-485. DOI: 10.1111/j.1540-8167.2011.02252.x.
[9]Andrikopoulos G, Tzeis S, Vardas PE. Invasive therapy for atrial fibrillation: recent developments in ablation, navigation and mapping technology[J]. Heart, 2011,97(3):237-243. DOI: 10.1136/hrt.2009.190017.
[10]Walfridsson U, Walfridsson H, Arestedt K, et al. Impact of radiofrequency ablation on health-related quality of life in patients with paroxysmal supraventricular tachycardia compared with a norm population one year after treatment[J]. Heart Lung, 2011,40(5):405-411. DOI: 10.1016/j.hrtlng.2010.09.004.
[11]Yildirim O, Yontar OC, Semiz M, et al. The effect of radiofrequency ablation treatment on quality of life and anxiety in patients with supraventricular tachycardia[J]. Eur Rev Med Pharmacol Sci, 2012,16(15):2108-2112.

服务与反馈:
文章下载】【加入收藏
copyright © 《中国医药》杂志编辑部
地址:北京市朝阳区安贞路2号首都医科大学附属北京安贞医院北楼二层    
电话:010-64456116     传真:010-64428528    邮编:100029
网址:www.chinamedicinej.com     Email: zgyy8888@163.com
当您在使用本网站投稿遇到困难时,请直接将稿件投送到编辑部邮箱zgyy8888@163.com
 京ICP备10041176号-1